FRATES JAMES M
SEC insider (Form 3/4/5 filer). CIK 0001235598. Chief Financial Officer at Amylyx Pharmaceuticals, Inc. (AMLX) and 1 other issuer. 17 reported Form 4/5 transactions since Sep 2024; latest on Sep 10, 2026. Located in CAMBRIDGE, MA.
Companies FRATES JAMES M has filed insider reports for
- Amylyx Pharmaceuticals, Inc. (AMLX): Officer, Chief Financial Officer
- Sage Therapeutics, Inc. (SAGE): Director
FRATES JAMES M
CIK: 0001235598
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 10, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect9.8K shares at avg. $32.27$315K - Sep 10, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect1K shares at avg. $33.23$35K - Aug 18, 2026AMLX
Amylyx Pharmaceuticals, Inc.
AwardDirect22.8K shares- - Mar 5, 2026AMLX
Amylyx Pharmaceuticals, Inc.
AwardDirect96K shares- - Mar 2, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect7.9K shares at avg. $14.52$115K - Feb 2, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect3.6K shares at avg. $14.65$52K - Jan 6, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect3.3K shares at avg. $11.11$37K - Sep 30, 2025AMLX
Amylyx Pharmaceuticals, Inc.
SaleDirect10.6K shares at avg. $14.65$155K - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
Tender OfferDirect2.8K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
21.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 10, 2026 |  AMLX Amylyx Pharmaceuticals, Inc. | Sale | 9,768 | $32.27 | $315,195 | Direct |
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 1,042 | $33.23 | $34,626 | Direct |
| Aug 18, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Award | 22,807 | - | $0 | Direct |
| Mar 5, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Award | 95,990 | - | $0 | Direct |
| Mar 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 7,909 | $14.52 | $114,851 | Direct |
| Feb 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 3,557 | $14.65 | $52,097 | Direct |
| Jan 6, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 3,326 | $11.11 | $36,954 | Direct |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale | 10,558 | $14.65 | $154,650 | Direct |
| Jul 31, 2025 |  SAGE Sage Therapeutics, Inc. | Tender Offer | 2,845 | - | - | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 21,500 | - | - | Direct |
1-10 of 17 transactions